Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

116.08USD
12:03pm EDT
Change (% chg)

$3.16 (+2.80%)
Prev Close
$112.92
Open
$111.14
Day's High
$118.40
Day's Low
$110.60
Volume
1,250,720
Avg. Vol
1,228,134
52-wk High
$118.40
52-wk Low
$31.38

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.27 December 22 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 2 2
(2) OUTPERFORM 8 7 7 7
(3) HOLD 6 8 8 8
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.28 2.28 2.35 2.35

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 16 24.70 64.57 15.93 11.50
Quarter Ending Dec-17 16 20.80 37.00 12.00 12.00
Year Ending Dec-17 19 78.76 121.84 56.59 59.97
Year Ending Dec-18 18 122.01 394.00 3.00 152.10
Earnings (per share)
Quarter Ending Sep-17 16 -1.27 -0.78 -1.64 -1.36
Quarter Ending Dec-17 16 -1.36 -1.10 -1.62 -1.47
Year Ending Dec-17 17 -5.19 -4.67 -5.87 -5.07
Year Ending Dec-18 17 -5.28 -1.99 -7.11 -3.86

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 22.31 15.93 6.38 28.60
Quarter Ending Mar-17 23.64 18.96 4.68 19.81
Quarter Ending Dec-16 10.95 17.45 6.50 59.40
Quarter Ending Sep-16 9.14 13.65 4.51 49.35
Quarter Ending Jun-16 8.09 8.71 0.62 7.64
Earnings (per share)
Quarter Ending Jun-17 -1.22 -1.34 0.12 -9.67
Quarter Ending Mar-17 -1.26 -1.25 0.01 -0.73
Quarter Ending Dec-16 -1.34 -1.32 0.02 -1.73
Quarter Ending Sep-16 -1.14 -1.21 0.07 -6.35
Quarter Ending Jun-16 -1.24 -1.05 0.19 -15.38

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 24.70 24.70 26.13 21.32 11.50
Quarter Ending Dec-17 20.80 20.80 20.39 18.97 12.00
Year Ending Dec-17 78.76 78.76 78.86 76.46 59.97
Year Ending Dec-18 122.01 117.36 119.24 139.85 152.10
Earnings (per share)
Quarter Ending Sep-17 -1.27 -1.25 -1.25 -1.29 -1.36
Quarter Ending Dec-17 -1.36 -1.35 -1.37 -1.38 -1.47
Year Ending Dec-17 -5.19 -5.19 -5.21 -5.23 -5.07
Year Ending Dec-18 -5.28 -5.29 -5.26 -4.94 -3.86

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 0 2
Quarter Ending Dec-17 0 0 1 1
Year Ending Dec-17 0 0 2 1
Year Ending Dec-18 7 1 7 2
Earnings
Quarter Ending Sep-17 0 1 1 3
Quarter Ending Dec-17 0 1 2 2
Year Ending Dec-17 0 2 2 2
Year Ending Dec-18 8 2 7 3